U.S. Capital Wealth Advisors’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,000
Closed -$93.3K 689
2023
Q4
$93.3K Hold
10,000
﹤0.01% 648
2023
Q3
$85.8K Sell
10,000
-8,263
-45% -$78.9K ﹤0.01% 618
2023
Q2
$182K Sell
18,263
-29,571
-62% -$296K 0.01% 631
2023
Q1
$483K Sell
47,834
-8,196
-15% -$83.3K 0.02% 436
2022
Q4
$576K Buy
56,030
+18,069
+48% +$182K 0.03% 427
2022
Q3
$361K Buy
37,961
+2,000
+6% +$22.3K 0.02% 502
2022
Q2
$386K Sell
35,961
-545
-1% -$6.32K 0.02% 515
2022
Q1
$468K Buy
+36,506
New +$466K 0.02% 527

Other funds holding GRX

U.S. Capital Wealth Advisors's GRX Position: Q1 2024 in Review

U.S. Capital Wealth Advisors sold out of Gabelli Healthcare & Wellness Trust (GRX) in Q1 2024, closing a stake of 10,000 shares — an estimated $93.3K sold.

U.S. Capital Wealth Advisors first reported a position in GRX in Q1 2022 and held it in 8 quarters. The position peaked at $576K in Q4 2022. 69 funds tracked by Wall St. Rank hold GRX as of Q1 2024.

  • U.S. Capital Wealth Advisors reported no remaining Gabelli Healthcare & Wellness Trust position as of Q1 2024 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 10,000 Gabelli Healthcare & Wellness Trust shares in Q1 2024, an estimated $93.3K.
  • U.S. Capital Wealth Advisors first reported a position in Gabelli Healthcare & Wellness Trust in Q1 2022 and held it in 8 quarters.
  • U.S. Capital Wealth Advisors's Gabelli Healthcare & Wellness Trust position peaked at $576K in Q4 2022.
  • 69 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q1 2024.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2024, filed 10 May 2024.